Cargando…

Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?

BACKGROUND: The benefit of vitamin K antagonists depends on the time within the therapeutic range (TTR). A patient’s previous TTR could be a factor in the decision to change the anticoagulation regimen. However, the predictive value of a previous TTR for a future TTR is not well established, nor is...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Miert, Jasper H. A., Veeger, Nic J. G. M., Meijer, Karina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article: Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292664/ https://www.ncbi.nlm.nih.gov/pubmed/32548559 http://dx.doi.org/10.1002/rth2.12328

Ejemplares similares

Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients
por: Rojo, Mario, et al.
Publicado: (2020)

Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis
por: van Miert, Jasper H. A., et al.
Publicado: (2018)

Paving the way for establishing a reference measurement system for standardization of plasma prothrombin time: Harmonizing the manual tilt tube method
por: van den Besselaar, Antonius M. H. P., et al.
Publicado: (2020)

Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes
por: Remer, Hallie B., et al.
Publicado: (2022)

TTR: Time in Therapeutic Range or “The Troublesome Report”?
por: Reiffel, James A.
Publicado: (2019)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Time in the Therapeutic Range (TTR): An Overly Simplified Conundrum
por: Reiffel, James A.
Publicado: (2017)

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen
por: Bar Barroeta, Awital, et al.
Publicado: (2022)

Growth differentiation factor‐15 for prediction of bleeding in cancer patients
por: Mulder, Frits I., et al.
Publicado: (2021)

Out‐of‐range INR results lead to increased health‐care utilization in four large anticoagulation clinics
por: Barnes, Geoffrey D, et al.
Publicado: (2018)

Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
por: Weiss, Lukas J., et al.
Publicado: (2022)

Variability in the Calculation of Time in Therapeutic Range for the Quality Control Measurement of Warfarin
por: Siddiqui, Safia, et al.
Publicado: (2018)

Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
por: Li, Yanni, et al.
Publicado: (2020)

Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation
por: Williams, Brent A., et al.
Publicado: (2017)

Predicting the risk of recurrent venous thrombosis: What the future might bring
por: Lijfering, Willem M., et al.
Publicado: (2019)

Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2022)

The incidence of cancer-associated thrombosis is increasing over time
por: Mahajan, Anjlee, et al.
Publicado: (2022)

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

Time in Therapeutic Range, as a Determinant of All‐Cause Mortality in Patients With Hypertension
por: Doumas, Michael, et al.
Publicado: (2017)

Identification of environmental and genetic factors that influence warfarin time in therapeutic range
por: Botton, Mariana R., et al.
Publicado: (2020)

Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower‐leg injury or knee arthroscopy
por: Mohammed, Yassene, et al.
Publicado: (2022)

PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke
por: Dhanesha, Nirav, et al.
Publicado: (2022)

Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
por: Sarkar, Amrita, et al.
Publicado: (2023)

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study
por: Wiegers, Hanke M. G., et al.
Publicado: (2021)

The intestinal microbiome potentially affects thrombin generation in human subjects
por: Mohammed, Yassene, et al.
Publicado: (2019)

Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
por: Wiegers, Hanke M. G., et al.
Publicado: (2022)

SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis
por: Tilburg, Julia, et al.
Publicado: (2020)

Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis
por: van Vught, Lonneke A., et al.
Publicado: (2021)

Anti‐β2‐glycoprotein I and anti‐prothrombin antibodies cause lupus anticoagulant through different mechanisms of action
por: Noordermeer, Tessa, et al.
Publicado: (2021)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns
por: Toorop, Myrthe M. A., et al.
Publicado: (2020)

Detection of upper extremity deep vein thrombosis by magnetic resonance non‐contrast thrombus imaging
por: van Dam, Lisette F., et al.
Publicado: (2021)

Safety of using the combination of the Wells rule and D‐dimer test for excluding acute recurrent ipsilateral deep vein thrombosis
por: van Dam, Lisette F., et al.
Publicado: (2020)

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin
por: Ting, Clara, et al.
Publicado: (2018)

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Unraveling a borderline antithrombin deficiency case with quantitative mass spectrometry
por: Kruijt, Mirjam, et al.
Publicado: (2021)

Post‐thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study
por: de Kleijn, Robert J. C. M. F., et al.
Publicado: (2022)

Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis
por: Erkens, Petra M. G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m466ri2q24a4ecagkkfs4japcn